KRAS and neoplasm: The SK-LU1 tumour growth was significantly inhibited when mice were treated with αEGFR-mAB-P/KRAS-siRNA/P nanostructures compared to PBS control group and to αEGFR-mAB-P/control-siRNA/P nanostructures (Fig. 6C).